Publisher
Springer Science and Business Media LLC
Reference147 articles.
1. Sultan, I., Qaddoumi, I., Yaser, S., Rodriguez-Galindo, C., & Ferrari, A. (2009). Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: an analysis of 2,600 patients. Journal of Clinical Oncology. https://doi.org/10.1200/JCO.2008.19.7483.
2. Saab, R., Spunt, S. L., & Skapek, S. X. (2011). Myogenesis and rhabdomyosarcoma. In Current topics in developmental biology (Vol. 94, pp. 197–234). doi:https://doi.org/10.1016/B978-0-12-380916-2.00007-3.
3. Ries, L. A. G., Smith, M. A., Gurney, J. G., Linet, M., Tamra, T., Young, J. L., & Bunin, G. R. (1999). Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995. NIH Pub. No. 99-4649, 179 pp.
4. Mai, P. L., Best, A. F., Peters, J. A., DeCastro, R. M., Khincha, P. P., Loud, J. T., et al. (2016). Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort. Cancer.
https://doi.org/10.1002/cncr.30248.
5. Sung, L., Anderson, J. R., Arndt, C., Raney, R. B., Meyer, W. H., & Pappo, A. S. (2004). Neurofibromatosis in children with rhabdomyosarcoma: a report from the intergroup rhabdomyosarcoma study IV. The Journal of Pediatrics. https://doi.org/10.1016/j.jpeds.2004.02.026.